Does insurance typically cover Restasis for dry eye or glaucoma-related eye inflammation?
Insurance may cover Restasis for dry eye disease, but coverage for glaucoma-related eye inflammation is less typical and often depends on individual policies.
Understanding the context
Patients considering Restasis often want to know if insurance will help pay for it, especially for chronic conditions like dry eye or inflammation linked to glaucoma treatment. Coverage usually depends on the specific reason it’s prescribed and the insurer’s formulary.
- Coverage is more likely for FDA-approved uses like chronic dry eye
- Use for eye inflammation from glaucoma medications may be off-label
- Patients may need prior authorization or step therapy requirements
This helps explain why it’s essential to understand how Restasis works and who typically benefits from it.
How Restasis works and who it helps
How it works
Restasis may work by reducing inflammation associated with chronic dry eye, helping the eyes naturally produce more tears.
According to Drugs.com, it contains cyclosporine, an immunosuppressant that helps increase tear production by reducing inflammation in the tear glands over time.
Clinical applications
Restasis is primarily used to treat chronic dry eye disease, especially in cases where tear production is suppressed due to eye surface inflammation. Limited data suggest it may sometimes be used off-label when inflammation arises from treatments like glaucoma medications, though this is less standard.
Because uses beyond dry eye treatment are not officially approved, insurance may not always cover them.
Safety and regulatory information
Safety profile
According to the Israeli Ministry of Health registration document, side effects of Restasis may include eye burning, stinging, redness, and discharge. These are generally mild to moderate.
Patients with active eye infections should avoid using Restasis unless directed by their healthcare provider.
FDA approval and indications
Restasis is FDA-approved for increasing tear production in patients with chronic dry eye linked to inflammation. It is not specifically approved to treat glaucoma-related eye inflammation.
Due to this limitation, off-label uses may not be covered by insurance plans—check with your insurer or prescriber first.
How to get Restasis safely
How to obtain safely
IsraelPharm offers international access to Restasis at competitive rates through its licensed online pharmacy. U.S. patients often use this as a cost-effective option when insurance does not cover their needs.
Always speak with your eye care provider before starting or switching medications.
Key Takeaways
- Restasis is approved to treat dry eye disease caused by eye inflammation
- Insurance is more likely to cover use for dry eye than for glaucoma-related eye inflammation
- Off-label uses like glaucoma-related inflammation may require additional justification
- Side effects are usually mild but should still be monitored by an eye specialist
- Patients can access Restasis from licensed pharmacies like IsraelPharm when insurance coverage is limited
Frequently Asked Questions
Can I use Restasis for inflammation caused by glaucoma treatment?
Restasis is not specifically approved for this use, but some doctors may prescribe it off-label if inflammation develops from other medications. Insurance coverage in such cases may be limited.
Is Restasis safe to use long-term?
Based on information from IsraelPharm’s dry eye blog, Restasis is often used long-term in chronic dry eye conditions under medical supervision. Regular check-ins with your eye doctor are essential.
How quickly does Restasis work?
According to IsraelPharm, noticeable improvement may take several weeks to months. Consistent use as prescribed is key for effectiveness.
Does insurance usually cover Restasis?
Coverage is more likely if prescribed for chronic dry eye approved by the FDA. Off-label uses, such as post-glaucoma inflammation, may not qualify for reimbursement without additional review or appeal.
Is Restasis the same as artificial tears?
No, artificial tears provide temporary relief through lubrication, while Restasis may help increase natural tear production by reducing inflammation over time.


